Prosus N.V. is rated Buy. PROSF stock saw strong Tencent growth, NAV discount, and profitable e-commerce drives value. See ...
Eli Lilly opens new Gateway Labs facility in San Diego to boost biotech innovation and collaboration
The pharmaceutical giant's fourth U.S. facility provides lab space for 15 companies working on cell therapy, cancer treatment and other medical breakthroughs.
Regeneron remains a 'Strong Buy' amid investor concerns and strong drug performances. Read here for more financial analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback